HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Ebrahimi-Fakhari Selected Research

Hamartoma

9/2017[ESPED-Survey: TSC-disease in children and adolescents: preliminary results from a German epidemiological survey].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Ebrahimi-Fakhari Research Topics

Disease

13Tuberous Sclerosis (Bourneville's Disease)
01/2023 - 03/2017
4Rhabdomyoma
12/2021 - 01/2018
3Neoplasms (Cancer)
09/2023 - 01/2021
3Angiomyolipoma
01/2022 - 01/2020
3Astrocytoma (Pilocytic Astrocytoma)
10/2021 - 01/2020
2Infections
09/2023 - 01/2023
2Inborn Genetic Diseases (Disease, Hereditary)
10/2021 - 01/2018
2Epilepsy (Aura)
01/2020 - 01/2018
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2019 - 01/2018
1Thrombosis (Thrombus)
01/2023
1Cysts
01/2022
1Hyperplasia
01/2022
1Drug Resistant Epilepsy
10/2021
1Primitive Neuroectodermal Tumors (PNET)
01/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021
1Polymicrogyria
10/2020
1Hereditary Spastic Paraplegia
10/2020
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
01/2020
1Muscle Weakness
08/2019
1Hemorrhage
03/2019
1Retinopathy of Prematurity (Retrolental Fibroplasia)
03/2019
1Bronchopulmonary Dysplasia
03/2019
1Kidney Diseases (Kidney Disease)
01/2019
1Patent Ductus Arteriosus
01/2019
1Birth Weight (Birth Weights)
01/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2019
1Hematologic Diseases (Blood Diseases)
07/2018
1Communicable Diseases (Infectious Diseases)
07/2018
1Seizures (Absence Seizure)
01/2018
1Pneumothorax
01/2018
1Disease Progression
01/2018
1Rare Diseases (Rare Disease)
11/2017
1Hamartoma
09/2017
1Skin Manifestations
07/2017
1Angiofibroma
03/2017

Drug/Important Bio-Agent (IBA)

11trans-sodium crocetinate (crocetin)IBA
01/2022 - 03/2017
4Sirolimus (Rapamycin)FDA Link
01/2023 - 03/2017
2EverolimusFDA Link
10/2021 - 01/2020
2MTOR InhibitorsIBA
01/2021 - 08/2020
2Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2018
2atalurenIBA
01/2019 - 01/2018
1TeicoplaninIBA
01/2023
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2023
1LipidsIBA
01/2022
1TOR Serine-Threonine KinasesIBA
01/2021
1IronIBA
10/2020
1Adaptor Protein Complex 4IBA
10/2020
1CannabidiolIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2019
1Lactic Acid (Lactate)FDA LinkGeneric
03/2019
1Ibuprofen (Motrin)FDA LinkGeneric
01/2019
1Gentamicins (Gentamicin)FDA LinkGeneric
01/2019
1Dihydrotachysterol (AT 10)IBA
01/2019
1CreatinineIBA
01/2019
1N 30IBA
07/2018
1DystrophinIBA
01/2018
1SteroidsIBA
01/2018
1CatecholaminesIBA
01/2018
1Nonsense Codon (Nonsense Mutation)IBA
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
07/2017

Therapy/Procedure

3Therapeutics
01/2023 - 08/2019
2Off-Label Use
01/2019 - 01/2018
1Cell Transplantation
09/2023
1Vascular Access Devices (Arterial Line)
01/2023
1Operative Surgical Procedures
01/2021